National Institutes of Health Career Development Awards for Cardiovascular Physician–Scientists Recent Trends and Strategies for Success by Lindman, Brian R. et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 6 , N O . 1 6 , 2 0 1 5
ª 2 0 1 5 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j a c c . 2 0 1 5 . 0 8 . 8 5 8THE PRESENT AND FUTURE
COUNCIL PERSPECTIVESNational Institutes of Health Career
Development Awards for
Cardiovascular Physician–Scientists
Recent Trends and Strategies for SuccessBrian R. Lindman, MD, MSCI,* Carl W. Tong, MD, PHD,y Drew E. Carlson, PHD,z C. William Balke, MD,*x
Elizabeth A. Jackson, MD, MPH,k Meena S. Madhur, MD, PHD,{ Ana Barac, MD, PHD,# Marwah Abdalla, MD, MPH,**
Evan L. Brittain, MD,{ Nihar Desai, MD, MPH,yy Andrew M. Kates, MD,* Andrew M. Freeman, MD,zz
Douglas L. Mann, MD*ABSTRACTTh
Co
Co
Fro
Me
dio
VA
Sch
Ce
De
(#2
NI
NI
Ce
02
Inv
po
ad
as
res
rec
fro
Dr
theNurturing the development of cardiovascular physician–scientist investigators is critical for sustained progress in car-
diovascular science and improving human health. The transition from an inexperienced trainee to an independent
physician–scientist is a multifaceted process requiring a sustained commitment from the trainee, mentors, and institution.
A cornerstone of this training process is a career development (K) award from the National Institutes of Health (NIH).
These awards generally require 75% of the awardee’s professional effort devoted to research aims and diverse career
development activities carried out in a mentored environment over a 5-year period. We report on recent success rates for
obtaining NIH K awards, provide strategies for preparing a successful application and navigating the early career period
for aspiring cardiovascular investigators, and offer cardiovascular division leadership perspectives regarding K awards in
the current era. Our objective is to offer practical advice that will equip trainees considering an investigator path for
success. (J Am Coll Cardiol 2015;66:1816–27) © 2015 by the American College of Cardiology Foundation.e views expressed in this paper by the American College of Cardiology’s (ACC’s) Academic Cardiology Section Leadership
uncil and the Early Career Section Leadership Council do not necessarily reﬂect the views of the Journal of the American
llege of Cardiology or the ACC.
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AND ACRONYM S
CDA = career development
award
CTSA = Clinical and
Translational Science Award
NHLBI = National Heart, Lung
and Blood Institute
NIH = National Institutes of
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1817T he creativity, passion, and intellectual capi-tal of cardiovascular physician–scientist in-vestigators fuel advances in cardiovascular
science that improve human health. Accordingly,
these investigators are an indispensable resource.
Unfortunately, ever-present ﬁnancial pressures and
myriad other forces now threaten the develop-
ment of talented individuals for this mission and
purpose, which may hinder continued innovation
and scientiﬁc progress (1–3). Shortsightedness in this
regard could have numerous adverse long-term
consequences.
The 2014 National Institutes of Health (NIH)
Physician-Scientist Workforce Working Group docu-
mented the aging and the declining size of the
physician–scientist workforce (4). This decline is in
stark contrast to increases in annual graduation
rates of life science PhDs, from <2,000 per year in 1993
to >8,000 per year in 2007 (5,6). If achieving inde-
pendence is deﬁned as obtaining a funded research
project grant (R01), the average time for MD/PhD
physician–scientists to achieve independence is
13 years from graduation, and the average time for MD
physician–scientists is 17 years from graduation (4).
Thus, it takes a considerable time to develop
physician–scientists who can pursue independent
research. With numerous challenges and obstacles
present and looming, a well-trained, diverse, re-
plenishing, and adequately sized cardiovascular
physician–scientist workforcemay now be in jeopardy.
Despite real challenges, this is also a time of un-
precedented opportunity for elucidating pathophysi-
ology and identifying novel preventive and
therapeutic strategies that improve cardiovascular
and overall health (2,7). To develop, harness, and
effectively utilize the technological resources
available to us, we need people—cardiovascular
physician–scientists—to drive this enterprise. Accord-
ingly, a team of authors, including a National Heart,
Lung, and Blood Institute (NHLBI) program ofﬁcer, a
past chairman of the NHLBI K-grant study section,
NIH K-grant study section reviewers, a cardiovascular
division chief, and a fellowship program director,
American College of Cardiology (ACC) leadership,
K-award mentors, and current K-award recipients
wrote this paper to inform, equip, and counsel
the aspiring early-career cardiovascular physician–
scientist. In several places throughout the paper,own and do not reﬂect the view of the National Institutes of Health, the Depar
Healthcare Research and Quality, or the United States Government. Drs. Lin
Listen to this manuscript’s audio summary by JACC Editor-in-Chief Dr. Vale
Manuscript received August 3, 2015; revised manuscript received August 24assertions aremadewithout ﬁrm, quantitative
data. As such, these assertions should be
regarded as the consensus opinion of a broad
authorship with extensive, multifaceted
experience relevant to the subjects covered.
Our objectives are to provide: 1) updated data
for cardiovascular K-award applicants to the
NHLBI regarding success rates for initial and
resubmission applications; 2) guidance for
preparation of each component of a competi-
tive K-award application; and 3) practical counsel for
what is important during this early career period
(before and after K-award funding) to maximize one’s
chance of achieving a sustained, independent research
program.
NIH CAREER DEVELOPMENT AWARDS
(K AWARDS)
A K award is a mentored career development award
(CDA) that is often the ﬁrst step taken after fellowship
training for those in pursuit of an independent
research career (8–10). The NIH Mentored Clinical
Scientist Research Career Development Award (K08)
and NIH Mentored Patient-Oriented Research Career
Development Award (K23) are the most common
early-career awards for clinician–scientists at the
instructor or assistant professor level (Table 1).
Although most aspiring physician–scientists apply for
a K08 or K23 award, some receive preparation as KL2
or K12 scholars funded by a Clinical and Translational
Science Award (CTSA) or an Institutional K12 Award
(Table 1). These CDAs typically provide up to 5 years
(2 to 3 years for a K12 or KL2) of salary support
($75,000 per year for CDAs funded by the NHLBI)
for the investigator, as well as research support
($25,000 to $50,000/year) for project expenses. The
key advantage of these awards is the provision/
requirement of 75% protected time for research and
other career development activities. The remaining
25% is devoted to clinical, administrative, or teach-
ing activities. For those in procedural specialties
(including surgical specialties, electrophysiology, and
interventional cardiology), it is often possible to
request a reduction in research effort to no less than
50% (13). This exception is speciﬁc for each Institute
within the NIH and needs to be discussed well in
advance with a designated program ofﬁcer on a
Healttment of Health and Human Services, the Agency for
dman and Tong contributed equally to the work.
ntin Fuster.
, 2015, accepted August 25, 2015.
TABLE 1 NIH Career Development Awards (K Awards)
KL2 or K12  These awards are made to institutions, which then select the recipient scholars through an internal competition.
 KL2/K12 support is typically 2 to 3 yrs; during this time, the scholar is expected to apply for subsequent funding, most often
either a K08 or K23 award.
 These awards may be particularly helpful for prospective investigators with very little prior research experience by allowing
them to take a few didactic classes, perform mentored research, and generate a couple of ﬁrst-author papers to make them
more competitive for an extended individual K award.
 Total time on KL2/K12 and K08 or K23 awards is typically limited to 6 yrs.
K23  The K23 award requires training in patient-oriented research, deﬁned by the NIH as research conducted with human subjects
(or on material of human origin, such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague)
directly interacts with human subjects. This area of research includes: 1) mechanisms of human disease; 2) therapeutic
interventions; 3) clinical trials; and 4) development of new technologies.
 Prospective K23 applicants who are unsure of whether their research meets this deﬁnition should contact NIH program staff
before submitting to determine if their work qualiﬁes, or if the K08 or another K funding opportunity is more appropriate.
 See PA-14-049 (11) for information on K23 awards.
K08  A common misconception is that the K08 award is only for basic science. Although basic science research (e.g., using cell
lines, animal models, or human tissues) is often supported by this mechanism, epidemiological, behavioral, health services,
and outcomes research utilizing existing databases that do not require interaction with human subjects are also supported by
this mechanism.
 See PA-14-046 (12) for information on K08 awards.
NIH ¼ National Institutes of Health.
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1818case-by-case basis. In the ﬁnal 2 years of a K award,
effort may be reduced to no less than 50% and
replaced with effort as a principal investigator (PI)
on a qualifying research grant supported by the
NIH (such as an R01 or a subproject of a multi-
project NIH grant) or other federal agencies (14),
provided the candidate remains in a mentored
environment.
Distinct from typical research awards, CDAs are
designed as much (or more) to promote the develop-
ment of the investigator as to accomplish speciﬁc
scientiﬁc aims. The career development plan should
be customized to the applicant, taking into account
his or her background, experience, and future goals.
The objective of the award is to provide a protected
period of intensive mentored research that yields
independent investigators with sustained and pro-
ductive scientiﬁc careers.
NIH K AWARDS–APPLICANTS
AND SUCCESS RATES
Over the last 10 years (2005 to 2014), there has been a
substantial decline in the number of applicants for
K awards to the NIH overall and to the NHLBI, partic-
ularly for K08 awards (Figure 1). Consistent with the
2014 NIH Physician-Scientist Workforce Working
Group Report, these data indicate that the pool of
early-career cardiovascular physician–scientists is
shrinking (4). K-grant success rates have varied be-
tween 20% and 40% over this period, with a notable
increase during 2009 to 2010 due to the American Re-
covery and Reinvestment Act. Despite the budgetary
constraints of the last few years (2011 to 2014), the
NHLBI has made an effort to maintain steady levels of
support for research training and career development;therefore, success rates remained comparable to the
years before the Recovery Act.
The decline in K08 physician–scientists has been
more marked than for K23 physician–scientists.
Although we lack empirical data that identify the
causes for these trends, we speculate that the fol-
lowing (and other) factors are likely contributing.
K08 applicants tend to pursue more basic science
research. Due to decreased funding at the NIH,
increased competition from PhD-only scientists for
NIH R01 dollars, and a paucity of funding sources for
basic science research outside of the NIH, prospective
K08 applicants may see a bleak, high-risk future and
decide not to pursue a physician–scientist pathway.
By contrast, prospective K23 applicants may see
similar trends, but may also see more potential non-
NIH funding options, including foundations and
device and pharmaceutical companies, and less
competition from PhD-only scientists for more clini-
cally focused research.
The data shown in Figure 2 for K-grant applications
assigned to the Division of Cardiovascular Sciences at
the NHLBI since 2011 provide the most current and
likely the best estimate of success for aspiring cardio-
vascular physician–scientists. From 2011 to 2015, a
total of 139 K08 and K23 applicants assigned to the
Division of Cardiovascular Sciences made resubmis-
sions. For this cohort, resubmitted proposals have a
much higher funding rate than original submissions,
highlighting that persistence pays off when applying
for a K award (Figure 2). Those applications that were
scored both initially (A0) and on resubmission (A1) had
a median improvement of 13 points. For the entire
A1 population, 84% received a better priority score on
the resubmission than on the initial application.
Among all of the resubmitted (A1) applications, 63%
FIGURE 1 Temporal Trends for K Grants Between 2005 and 2014
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The NIH deﬁnes the success rate as the number of applications funded divided by the number of applications reviewed within a ﬁscal year; however, original
submissions (A0) and resubmissions (A1) on the same project submitted within the same ﬁscal year are counted as 1 application. Accordingly, the success
rate is on the basis of applicants per ﬁscal year (15). (A) NHLBI K-08. (B) NHLBI K-23. (C) Total NIH K-08. (D) Total NIH K-23. NIH ¼ National Institutes of
Health; NHLBI ¼ National Heart, Lung, and Blood Institute.
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1819received scores in the high-impact range (priority
score 10 to 30; potentially fundable) (Table 2). Even
among 38 applicants whose initial proposal was not
discussed (because reviewer feedback before the
study section meeting indicated that it would not be
competitive for funding), 37% of their resubmitted
applications were judged to have a high impact.
Despite these encouraging data on the success rate of
resubmissions, less than one-half of applicants whose
initial proposal was not funded resubmitted a K pro-
posal (Table 2).
PROFILE OF A SUCCESSFUL
K AWARD APPLICATION
The foundation for a successful K-award application
begins with careful preparation long before the actual
application is constructed and submitted (see the
Practical Steps–Before and After the Award section).However, successful applicants have various levels of
prior research training and experience. Some may
have formal and more extensive research training
(e.g., PhD or MSc), whereas others may not. Publica-
tion records may differ in length and impact. Ulti-
mately, successful K-award applicants are able to
provide a compelling case for their likelihood to
develop into an independent investigator, but there is
no speciﬁc or precise mold into which one must ﬁt.
The 5 scored components of K-award proposals
consist of: 1) the candidate; 2) the career development
plan/career goals and objectives; 3) the research plan;
4) mentor(s), co-mentor(s), consultant(s), collabora-
tor(s); and 5) the environment and institutional
commitment to the candidate. These 5 components
must cohesively and synergistically ﬁt together in
a uniﬁed and mutually reinforcing manner. We
recommend that prospective applicants read several
successful K-award proposals (not necessarily in their
FIGURE 2 Original Submission Versus Resubmission Trends From the
NHLBI Cardiovascular Sciences Division
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Funding rates are calculated per proposal. Data provided by the NHLBI
Cardiovascular Sciences Division for 2011 to 2014. This period was chosen
to reﬂect the current funding climate. (A) K-08. (B) K-23. A0 ¼ original
submission; A1 ¼ resubmission. Abbreviations as in Figure 1.
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1820area of proposed research) to provide ideas and
guidance on how to integrate these 5 components
into a compelling proposal. Many academic in-
stitutions formally or informally make sampleNHLBI (Cardiovascular) 2011 to 2014 Overall Rates for
roposals and Resubmissions: K08 and K23
0) proposals that were not discussed (triaged) 35%
resubmission rate for A0 proposals not funded 46%
ion (A1) applications that received a fundable
y score (#30)*
63%
tions (initially not discussed/triaged) that received a
le priority score (#30)
37%
nding rate for 2011–2014, including original proposals
submissions
31%
15, a priority score #30 was funded.
National Heart, Lung, and Blood Institute.applications available to prospective applicants.
There is an art to crafting a competitive application
that effectively sells the candidate and proposed
plan.
CANDIDATE. The applicant has to demonstrate
commitment to and passion for research, as well as
strong potential for achieving independence. Dedi-
cation of signiﬁcant time during fellowship toward
research, productivity during that time, and other
evidence of initiative, drive, and persistence tangibly
demonstrate this commitment and passion. The
publication record in the candidate’s Biosketch is
particularly important. K-grant review panels look
carefully, not just at the number of papers, but more
importantly, at their quality, author order, and genre
(e.g., original research, review, or editorial) in rela-
tion to the candidate’s past experience and long-term
goals. First-author research papers in well-regarded
journals carry the most weight. One or more coau-
thorships with the mentor indicate that a working
relationship has been established. One needs to
communicate thoughtful long-term career goals and
identify how the CDA will provide the necessary skills
and foundation to achieve those goals. A research
proposal in a unique niche or one that is likely to have
a high impact with numerous avenues for potential
future funding, will be viewed favorably, because it
indicates a greater likelihood of long-term sustain-
ability for the research program. The primary men-
tor’s letter and other reference letters must convey
and corroborate the personal characteristics, quali-
ties, and potential of the candidate. These individuals
ought to know the candidate well and be able to give
speciﬁc evidence of the candidate’s potential for a
productive, independent scientiﬁc career.
CAREER DEVELOPMENT PLAN/CAREER GOALS AND
OBJECTIVES. Although there is no one-size-ﬁts-all
approach to career development plans, the applicant
should clearly identify knowledge, skill, experiential,
or other gaps to be addressed during this phase of
training that will help facilitate development into an
independent investigator. The career development
plan must provide: 1) personalized steps toward
meeting career goals; 2) harmonious integration with
the research plan; and 3) a pathway toward indepen-
dence that builds on prior experience and training. A
program that involves foundational didactic courses
(that may even lead to a degree) is appropriate for
those with little or no formal research training; for
those with a PhD, MPH, or MSc, a few selective courses
to address speciﬁc knowledge gaps will be more
appropriate. Informal or creative learning experi-
ences, such as a visiting rotation, workshop, or other
J A C C V O L . 6 6 , N O . 1 6 , 2 0 1 5 Lindman et al.
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1821mechanisms to learn a new technique, method, or
approach may also be incorporated into the plan.
Formal and informal learning must directly support
the scientiﬁc aims by topic and by timing (e.g., an
applicant ought to take an epigenetics course during
year 1 to support conducting research on a related
speciﬁc aim in year 2. A clear and speciﬁc plan/
schedule for mentor–mentee and advisory committee
meetings (and content to be covered) should be out-
lined, along with reasons particular mentors were
chosen. This plan should be corroborated in the letters
from the primary mentor and mentor committee.
Concrete milestones for progress should be included
(e.g., number of abstracts or publications per year,
recruitment goals, and so on), as well as speciﬁc plans
for transitioning to an R01 application. Tables and
timelines should be used to succinctly convey key
components of the career development plan.
RESEARCH PLAN. The proposed research must
demonstrate scientiﬁc merit, appropriateness for
career stage, and opportunities for obtaining new
research skills. Although a simplistic scientiﬁc pro-
posal will not be competitive, an overly ambitious
proposal is commonly submitted and will be poorly
received. There needs to be an appropriate balance
between innovation and feasibility (in terms of
budget, time, and scope). The aims ought to serve as a
training vehicle for the applicant, so that important
skills are acquired that can readily be translated to
future work. The aims should also be connected, but
not dependent from one another in such a way that if
Aim 1 fails, then Aims 2 and 3 are no longer viable.
Preliminary data (particularly when generated by the
applicant) is certainly helpful, but, in many circum-
stances, not required for each Aim. If a relatively new
technique is proposed, the applicant should demon-
strate either personal experience with the technique
(e.g., published paper), a mentor with expertise, or a
clear plan to obtain relevant training. Analytic plans
need to be sound and power calculations included
where appropriate. The proposal must demonstrate an
awareness of potential problems and indicate alter-
native strategies, integrate well with the career
development plan and the expertise of the mentor,
and build a foundation for the next step of experi-
ments that are likely to be proposed in an R01.
MENTOR(S), CO-MENTOR(S), CONSULTANT(S), COLLAB-
ORATOR(S). Mentoring is a crucial component of a
successful K application. Although the analogy is
not perfect, to some extent the mentor is viewed as
the collateral on the NIH’s investment in an unproven
and unpolished young investigator. The mentor
will play a prominent and inﬂuential role indetermining whether this investment yields a favor-
able return in the form of a productive, independent
investigator. Accordingly, the mentor needs to be a
recognized leader in his or her ﬁeld of research,
actively publishing, with a steady history of support
from major peer-reviewed grants (e.g., NIH R01, VA
MERIT Award, and the like). Applicants should explain
how both the amount of resources available and
the quality of science are equivalent to that typical
of R01-funded investigators when their mentors are
supported mostly by private foundations or industry.
The qualities, track record of prior successful
mentorship (i.e., trainee table), and commitment of
the mentor are more important than an exact overlap
between the mentor’s research and the proposed
aims. The selection of the mentor needs to ﬁt with the
applicant’s stated goals, identiﬁed knowledge and
skill gaps, and proposed research. The mentor letter
must precisely describe the planned interaction with
the mentee, the skills and knowledge that will be
imparted, benchmarks for progression, criteria for
evaluation, and plan for the transition to indepen-
dence. This description should align with what is
stated in the career development plan of the applicant.
If there are questions regarding how and whether a
speciﬁc portion of the mentor’s research portfolio will
be passed on to the applicant, those should be
addressed. The ﬁngerprints and oversight of the
mentor need to be evident in the crafting of the
applicant’s proposal to demonstrate the engagement
and commitment of the mentor; lack of such involve-
ment is evident to experienced reviewers and raises
a cautionary ﬂag. Although not required, a mentoring
committee is commonly used to provide expertise in
multiple areas that cannot be covered by just 1 person.
A committee can also add expertise that does not
exist in the home institution and can provide a balance
of scientiﬁc and clinical perspectives. The primary
mentor can coordinate and organize the individuals
on the committee for the beneﬁt of the candidate’s
scientiﬁc and career development.
ENVIRONMENT AND INSTITUTIONAL COMMITMENT
TO THE CANDIDATE. There must be a clear commit-
ment of the institution to the development of the ap-
plicant’s scientiﬁc career. This is demonstrated by the
provision of sufﬁcient resources in terms of time,
space, equipment, technician or research coordinator,
and start-up funds. The institutional provisions
should not be conditional upon the applicant receiv-
ing the K award, as reviewers will interpret this as a
lack of institutional commitment. Although it may not
be as important for applicants pursuing clinical
research, appointment to a tenure-track position also
TABLE 3 Checklist: Major Components of Preparing a K-Award Application
Identify a primary mentor
Identify a mentorship team
Develop and reﬁne hypotheses and speciﬁc aims before writing the research plan
Research plan
Depending on prior training, identify an appropriate didactic curriculum
Identify informal learning experiences and other proposed career development activities
Career development plan
NIH Biosketch—exploit Section A
Protection of human subjects and/or animal use, resource sharing, biohazards, select agents
Responsible conduct of research
Reference letters—suggest points that referees may highlight in their letters
Budget—allow time to receive quotes for services or equipment
Allow time for experienced colleagues or a mock study section to read and critique the grant
as a whole
Letters from mentor, mentoring committee, collaborators, consultants, and institution
(to demonstrate institutional commitment)
NIH ¼ National Institutes of Health.
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1822demonstrates that the applicant is viewed as a prom-
ising contributor to the research mission of the insti-
tution. The provision of at least 75% protected time
during the period of the award for research and career
development activities needs to be clearly stated; if
the applicant currently does not have that much
protected time, it needs to be clear what and how
certain clinical activities will be relieved. Someone
who holds the authority to commit the institution
needs to write a letter that expresses institutional
commitment (e.g., department chair, medical school
dean). Although sometimes discounted, the strengths
and richness of the environment for the individual
applicant and their speciﬁc research program needs to
be clearly and speciﬁcally outlined, including intel-
lectual resources, core facilities or unique equipment,
collaborative relationships, statistical expertise, mock
study sections for grant preparation, career develop-
ment seminars, and so on.
OTHER AREAS. There are a few nonscored areas that
require careful planning. Training in the responsible
conduct of research is a federal mandate, so a clear
plan that demonstrates compliance is necessary. If
animals are used, the “Vertebrate Animal” section
needs to describe the proposed research (e.g., colony
size and timing must be appropriate for the proposed
research). For clinical studies, the “Protection of
Human Subjects” section needs to be clearly and
carefully completed. The budget needs to be realistic
and appropriate for the proposed research. If the
proposed aims cannot be carried out with the project
support available for a K award, there must be a clear
description of resources that will be used for the
funding gap (e.g., mentor’s funds, start-up funds
from the institution); such support should also becorroborated in the mentor’s letter and the institu-
tional commitment letter. Resource sharing, bio-
hazards, and select agents also need to be addressed,
even when these elements are not part of the project.
The current versions of the SF424 and institute-
speciﬁc instructions should be followed carefully.
All applications receive an initial administrative re-
view, and those that are noncompliant are withdrawn
from consideration, thereby delaying an eventual
submission by 1 or more review cycles.
Writing an outstanding K-award application re-
quires time; it may take 6 to 12months for all the pieces
to come together into a competitive application
(Table 3). Common pitfalls to avoid in the preparation
of a K-award application are outlined in Table 4.
PRACTICAL STEPS:
BEFORE AND DURING THE AWARD
KEY STEPS DURING FELLOWSHIP YEARS. Mentors .
The importance of mentorship cannot be overstated,
especially during the early stages of development on
an investigator path. Creativity, asking the “right”/
fundable questions, project development, scientiﬁc
writing, contextualizing, and messaging results,
initiating collaborations, and other valuable skills are
passed on, in part, via personal knowledge, in which
the mentor transmits a craft or trade, more than facts
to know or a formula to follow (16). In other words,
these skills are imparted via an interactive and per-
sonal exchange, not by following a set of rules or
guidelines. The mentor–mentee relationship is a
reciprocal, collaborative alliance, rather than a 1-way
relationship (17,18). In view of the increasing com-
plexity and multidisciplinary nature of research and
the breadth of knowledge and skills to be transmitted
to the mentee, additional mentors are often needed.
It is helpful to identify a cadre of additional mentors
who have navigated different segments of the inves-
tigator path successfully, including those who are
midcareer/senior, as well as more junior (perhaps on
CDAs). Meetings speciﬁcally designed to convey
wisdom and guidance from senior to junior in-
vestigators (e.g., How to Become a Cardiovascular
Investigator, directed by Valentin Fuster, MD, PhD)
are invaluable.
Pro jec ts and wr i t ing . Whereas initially one may get
involved in research projects that are primarily those
developed by a mentor, there needs to be some
transition from functioning as a cog in the wheel of
someone else’s research machine to developing and
reﬁning one’s own ideas. Learning from a seasoned
mentor how to ask good questions, not just conve-
nient questions, is an important skill. Although overly
TABLE 4 Common Pitfalls Responsible for Unsuccessful NIH K Award Applications
General
 Unresponsive to the speciﬁcs of the program announcement (e.g., no demonstrable PI contact with patients/research participants in a
K23 application)
 Sloppy construction with frequent errors in spelling/syntax
 For revised applications, being unresponsive to the prior critique—meaning not addressing the major concerns of each reviewer
Candidate
 Inadequate scholarly productivity for stage in career development
 Unexplained lapses in career development
 Sloppy construction of the NIH Biosketch with admixing of peer-reviewed manuscripts, abstracts, review articles—interpreted as lack of
mentor engagement
 Inclusion of articles in preparation or under review in the Biosketch
 Reference letters that are less than uniformly laudatory and/or template duplicates
 Failure of the candidate to educate the referee as to the goals/objectives of the speciﬁc K award
Career development plan/career goals and objectives
 Career development activities not aligned with the candidate’s background and/or long-term career goals
 No discussion of timing/approach to the crucial K-R transition, namely no plans for generation and submission of an R01 in the w3rd to
4th year of the K award
 Lack of details regarding training in survival skills (e.g., grant writing, manuscript generation, leadership skills, and so on) necessary for a
durable academic investigative career
 Lack of an advisory committee—highly desirable (although not required) in applications with multiple mentors/collaborators/consultants
and in those applications that engage multiple sites
 Lack of speciﬁcity of the metrics by which the candidate will be able to gauge his progress along the career development path
 Failure to align career development activities with known strengths of the institution, such as participation in the educational offerings
of the institution’s CTSA program
Research plan
 Lack of an organizing hypothesis and/or inclusion of descriptive speciﬁc aims
 Unclear overall focus and/or overly ambitious
 Interdependent (rather than interrelated) speciﬁc aims
 Incomplete discussion of analytic approach/expectations
 Inadequacies in consideration of potential pitfalls/confounders and incomplete discussion of potential strategies to minimize these,
should they be encountered
Mentor(s), co-mentor(s), consultant(s), collaborator(s)
 Mentor team not aligned with the candidate’s career goals/objectives, namely inadequate rationale for the inclusion of each mentor
 Inadequate details for the frequency, duration, and content of the mentoring contact of the candidate with each of the mentors,
particularly the primary mentor
 Inclusion of a primary mentor at a different institution than the candidate
 Lack of mentoring track record for some/all of the mentors
 Primary mentor without active major peer-reviewed grant support
 Lack of speciﬁcity of the metrics by which the mentor will be able to gauge the candidate’s progress along the career development path
Environment and institutional commitment to the candidate
 Boilerplate description of the institution’s capabilities/resources, rather than a review of unique strengths relevant to the speciﬁc
candidate (e.g., technologies, patient populations, specialized centers, unique databases, tissue sample repositories, etc.) and their
career goals
 Lack of speciﬁcity of the institutional commitment to the candidate including what is being provided (rank, space, start-up funds) and
what is being limited/protected (e.g., percent effort, administrative/clinical/teaching responsibilities)
 Absence of a clear discussion of how the candidate’s research will be supported ﬁnancially given that the research budget of typical
K award applications is generally not sufﬁcient to fund the proposed research
 Statements to the effect that institutional support is contingent upon the receipt of the K award
CTSA ¼ Clinical and Translational Science Award; NIH ¼ National Institutes of Health; PI ¼ principal investigator.
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to start small, learn the process, and then expand.
Working to bring 1 or 2 projects to completion, rather
than getting involved in multiple projects that ﬁzzle,
will establish traction and momentum. By turning a
submitted abstract into a manuscript, one gains
valuable experience with the process of communi-
cating results and learning the art of scientiﬁc
writing. Learning to write well is an incredibly
important skill that is learned by practice, input from
a constructively critical mentor(s), and via scientiﬁc
writing workshops or courses.
Protected t ime. Carving out some protected time
during fellowship is important to provide a sustainedperiod (several months to a year or more) devoted to
research. Basic science projects will require addi-
tional time (i.e., research time $2 years). If available
at your institution, a NIH T32 (training grant) is an
ideal mechanism to gain protected time. This time is
often needed to lay an adequate foundation for a
successful CDA application.
In t rospect ion . Having spent so many years of
training doing and saying the right thing to jump
through the next hoop, one must now take an honest
personal inventory (of strengths, weaknesses, pas-
sions, desires, and so on) and ask whether an inves-
tigator path is the right ﬁt. For some, the desire and
decision (to pursue or not pursue an investigator
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make an informed decision, clarity may require a 1- to
2-year substantive investment in research during
fellowship (taking the aforementioned steps). Either
way, one needs to honestly determine whether
research is exhilarating and rewarding, or more of a
chore and obligation. If there is no ﬁre in the belly
for an investigator path, it is important to recognize
and acknowledge that early. Pragmatically, it is also
important to consider some of the ﬁnancial costs (at
least initially) of choosing an investigator path that
will typically include lower wages due to fewer clin-
ical duties and less volume (1). Although this can be
somewhat offset by programs such as the NIH loan
repayment program, the near-term ﬁnancial loss
needs to be acknowledged.
SYNERGIZE YOUR CLINICAL FOCUS AND RESEARCH
FOCUS. Given the limited time and numerous de-
mands that early-career investigators face, synergiz-
ing one’s clinical niche and research focus to
reinforce one another, rather than compete, can be
particularly helpful. Numerous specialized clinical
topics (e.g., cardio-oncology, genetics of cardiomy-
opathy, heart failure with preserved ejection fraction,
valvular disease, vascular medicine, among others)
permit a young investigator to develop a specialty
clinic and a focused inpatient consult service. A pro-
spective registry could be developed that enrolls all
the patients seen, including detailed clinical and im-
aging data for careful phenotyping alongside a bio-
bank of blood (and perhaps tissue) specimens, with
prospective follow-up for clinical outcomes. Such a
registry could provide preliminary data and the
infrastructure for future intervention studies, and
could also facilitate new intramural or extramural
research collaborations, perhaps extending outside
the immediate ﬁeld of interest. Additional challenges
are faced by those pursuing a procedure-based area of
expertise (e.g., interventionalists, electrophysiolo-
gists), given the need to develop procedural compe-
tencies while ﬁnding sufﬁcient time for research.
FOCUS, FOCUS, FOCUS. Narrow and deep. Those
drawn to research are often curious about many
topics, thus making it difﬁcult to focus their investi-
gative efforts. But if one’s research questions and
effort are too diffuse, it will be difﬁcult to gain trac-
tion in any area. It is vital to be narrow and deep
before expanding and broadening.
F i rs t -author papers . At an early stage, one ought to
focus on writing several ﬁrst-author papers as the
primary driver of the project and writing. This pro-
ductivity lays the foundation for one’s independent
research program and can lead to additionalcommitments from the institution, such as indepen-
dent laboratory space and/or promotion. It is then
often appropriate, in consultation with one’s men-
tor(s), to transition to senior-author papers, as evi-
dence of one’s progression to independence and
readiness for R01 funding. Although there is a role for
being a contributing/middle author on some papers,
particularly at an early stage, avoid overcommitting
on papers where you are not the ﬁrst or last author.
For a research track, middle-author papers count
signiﬁcantly less for advancement and establishing
your expertise in a ﬁeld.
Learn to say no . Although it can be ﬂattering to be
asked by more senior colleagues to be on various
committees (either institutional or in state or national
organizations), it is important to be discerning and
thoughtful about which invitations to accept. It is
often important to say no to involvement on com-
mittees that will incur numerous meetings and tasks
that will drain your time and distract you from
development as an investigator. It may be strategic to
say yes to select opportunities if they will purpose-
fully advance your career development as a young
investigator by enabling you to make important con-
tacts that may include productive research collabo-
rations and opportunities. Similarly, one should
avoid too many educational commitments, particu-
larly preparing time-consuming lectures for trainees
or other audiences. A mentor can be helpful in
providing protection from these requests, if needed.
Enter into mentor ing s lowly . Many young, ener-
getic, early-stage investigators feel the desire to give
back and pass on what they are learning by mentoring
those more junior (medical students, residents, etc.).
However, this responsibility can be time consuming
and impede one’s ability to build a strong foundation
when it is most critical. It is helpful to take a long view
and realize that some selﬁshness with one’s time at an
early stage is important and necessary to establish a
viable independent research career. If this is done, one
canmentor numerous trainees over a sustained career.
Compartmenta l i ze c l in i ca l act iv i ty . It is essential
to avoid clinical activities that bleed too much into
time that is supposed to be protected for research.
Large outpatient practices or a clinical leadership po-
sition can cause repetitive, unpredictable intrusions
on research time and focus. It can be helpful to have
deﬁned blocks of clinical activity spaced out to allow
for longer stretches of focused research activity. One
should also try to avoid scheduling clinical activities
during predictable grant application periods.
RESUBMIT YOUR GRANT APPLICATION. It can be
devastating for an applicant who has put so much
TABLE 5 Examples of Additional Funding to Complement a K Award
American Heart Association (Grant-in-Aid, Mentored Clinical and
Population Research Award, Fellow-to-Faculty Transition Award)
American College of Cardiology Foundation (ACCF/William F. Keating Endowment
Career Development Award, ACCF/Merck Research Fellowships in
Cardiovascular Disease and Cardiometabolic Disorders)
Doris Duke Charitable Foundation (Clinical Scientist Development Award)
Burroughs-Wellcome Fund (Career Awards for Medical Scientists)
NIH Investigator Research Supplement
Gilead Sciences Research Scholars Program in Cardiovascular Disease
Institutional pilot awards
Related foundations (American Diabetes Association, Juvenile Diabetes Research
Foundation Career Development Award, Susan G. Komen Foundation, and so on)
NIH ¼ National Institutes of Health.
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1825time, effort, and emotion into a grant application to
have it receive an unfundable score (or not be scored at
all). Although there may be some fatal ﬂaws that
cannot be overcome, usually the quickest way to get
funded is to carefully review and responsively address
the critiques of the reviewers and resubmit the grant.
This applies for CDAs, as well as for many other
applications. The success rate is much higher for
resubmitted applications (Figure 2). One should allow
time to get over feelings of disappointment and anger
elicited by an unfavorable review and then work with
mentors to improve the proposal to address the con-
cerns of the reviewers. Contacting the NIH program
ofﬁcer or scientiﬁc review ofﬁcer assigned to the
application may provide strategic insights for making
the revision more competitive.
OBTAIN ADDITIONAL FUNDING. Research is expen-
sive, and the project support provided in a CDA is
very limited. It is assumed that one’s mentor will help
support the proposed work (emphasizing the impor-
tance of choosing a mentor or mentors who are well-
funded). However, even with mentor support, there
is often a need for more money to support work that
will provide a foundation for an independent R01
award. Recipients of CDAs are candidates for
numerous potential awards before obtaining R01
funding (sometimes explicitly called “bridging
awards”), many offered by foundations and some
offered by industry (Table 5). It is vital to not overlook
applying for awards that are related to one’s area of
research, even though they are not speciﬁcally car-
diovascular (e.g., funding agencies for research on
diabetes, older adults, oncology, among others). To
increase the chance of getting an idea/proposal fun-
ded by some agency, the same idea (with appropriate
adaptations pertinent to the particular award guide-
lines) may be submitted to multiple funding agencies.
This is a more efﬁcient strategy than submitting
distinct grants to each potential funding agency. If
multiple agencies fund a particular idea, the best
award can generally be chosen.
DEVELOP COLLABORATIONS, NETWORKS, AND TEAMS.
Increasingly, there are research questions that cannot
be answered by single-center studies, and it is
becoming more essential to collaborate with like-
minded investigators across your institution and at
other centers in networks and teams. One should be
aware, however, that there can be challenges
to carving out the individual contribution made in
this setting (particularly at a junior stage), and some
of these networks/teams can take years to grow.
Leveraging existing registries (e.g., the National Car-
diovascular Data Registry [NCDR]) to answer somequestions may be more expeditious and efﬁcient. The
recently launched ACC Research Network seeks to
connect investigators across the college and country
to promote mentorship and productive research col-
laborations (19).
PREPARING FOR AN R01. The primary purpose of an
NIH K award is to develop early-stage cardiovascular
investigators into independent scientists, usually
marked by an independent NIH R01 award. One
should anticipate that the ﬁrst R01 application may
not get funded and require resubmission, so the time
from initial submission to eventual funding could be
up to 18 to 24 months. As such, an R01 application
should be submitted approximately 2 to 3 years
before the end of the CDA. To have a competitive and
timely R01 application, a careful plan needs to be
established to obtain the necessary preliminary data,
papers that may be critical to the R01 application
should be published, and the viability of collabora-
tions that are important for the R01 proposal
demonstrated.
FROM THE PERSPECTIVE OF THE
CARDIOVASCULAR DIVISION LEADERSHIP
Throughout the history of medicine, cardiovascular
physician–scientists have played an important role
in the advancement of medical knowledge and
the development of new therapeutic approaches. In-
formed by their experience in caring for patients,
and armed with rigorous training to ask and answer
clinically important questions, physician–scientists
are uniquely positioned at the crossroads between
fundamental biomedical discovery and clinical prac-
tice. Accordingly, fostering the investigative careers
of physicians in training and/or junior faculty is in
the best interest of society, and thus is one of the
most important missions of physicians in leadership
CENTRAL ILLUSTRATION Strategies for Success as an Early-Stage Cardiovascular Physician–Scientist
Prospective 
cardiovascular 
physician-
scientist
Independent 
cardiovascular 
physician-
scientist
(R01)
Practical steps before and during the K Award
Focus, focus, focus
• Synergize clinical and research niche, compartmentalize clinical activity
• Learn to say “no” to involvement in committees and non-essentials
• Conduct narrow and deep research before expanding and branching out
• Enter into mentoring slowly
• Prepare competitive and timely R01 proposal, publish relevant key papers
Personal development
• Time management
• Learn to prioritize
• Growth as leader of a team
• Develop as a mentor
Professional development
• Develop collaborations, 
networks, and teams
and transition to senior author
• Get on key working/
writing groups
• Obtain additional funding
National Institutes of Health (NIH) K Award
1. The candidate
2. Career goals and objectives
3. Research plan
4. Mentor(s), co-mentor(s), collaborator(s)
5. Environment and institutional commitment to the candidate
Pre K Award
During fellowship:
• Carve out protected
time for research
• Identify primary 
mentor and 
additional mentor(s)
• Initiate small 
projects, learn the 
research process
• Learn to write well 
from mentors and 
writing workshops
author paper(s)
• Introspection for 
clarity on future 
decisions
Lindman, B.R. et al. J Am Coll Cardiol. 2015; 66(16):1816–27.
An NIH K award combined with solid mentorship and multiple other aspects of personal and professional development are instrumental to the training of
an independent investigator. NIH ¼ National Institutes of Health.
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with the knowledge that health care is under siege,
now and for the indeﬁnite future, and that ﬁscal
stewardship of divisional resources is also an impor-
tant role of leadership. Thus, from the divisional
perspective, during a time of declining clinical mar-
gins, the challenge is to ﬁnd a way to support research
training and still maintain a balanced budget in order
to preserve the other missions of the division and/or
the department.
Although the value of physician–scientists to soci-
ety and the world is, in our view, priceless, the cost of
training physician–scientists is not an inexpensive
undertaking from the divisional perspective. Training
physician–scientists takes longer today than yesterday
because the research questions are more complex;
hence, the knowledge base required to be competitive
takes longer to acquire. Furthermore, the increasing
training requirements mandated by the Accreditation
Council for Graduate Medical Education (ACGME) and
American Board of Internal Medicine (ABIM) during
the clinical years of training, and the complexity of
clinical training resulting from the incredible ad-
vances in cardiovascular medicine leave little time for
research training, let alone scholarship, during the
clinical years of training. Whereas training physician–scientists could typically be accomplished within
3 years previously, given the complexity of training
required to be competitive, it now requires 5 (or more)
years of substantial protected time. Although the
amount of time required for proper research training
has never been clearly established, our experience has
been that 75% to 80% protected research time for
cognitive subspecialists and a minimum of 50% pro-
tected time for interventional/invasive subspecialists
allows for proper training and support of physician–
scientists. This requires a substantial ﬁnancial
commitment on the part of the sponsoring institution
because of the need to cost-share that portion of the
salary not supported by clinical revenue during
training. Given the pressure on health care reim-
bursement, and the cutbacks that have occurred in
cardiology over the past 5 years, the margins that used
to support the training of physician–scientists simply
no longer exist in most divisional budgets. Supporting
a cardiovascular physician–scientist until the time of
their ﬁrst R01 (or equivalent) grant, excluding start-up
support, can (conservatively) cost between $375,000
to $750,000 per trainee. When multiplied by the
number of physician–scientists in training at one time,
the annual amount of support required can approach
1 million dollars per year, depending on the number
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1827of young research faculty. Viewed within this very
pragmatic context, the need to encourage trainees and
junior faculty to obtain CDAs is obvious. Beyond these
pragmatic economic concerns, the most important
reason to encourage trainees and junior faculty to
obtain CDAs is to ensure that they obtain rigorous
research training and are allowed the requisite time to
develop into independent scientists with sustainable
research programs. In the end, for those in positions of
leadership and mentorship, the sense of satisfaction
that one gets from watching trainees become inde-
pendent investigators is simply an unparalleled pro-
fessional experience.
CONCLUSIONS
Tremendous opportunities now exist for advancing
knowledge and improving cardiovascular health. In
the face of myriad threats, the nurturing of talented,
capable, and sufﬁciently equipped cardiovascular
physician–scientists remains an indispensable prior-
ity. Shortcuts in this training mission will lead to an
inability to make sustained advances in the years
ahead. Individuals who desire to develop into inde-
pendent investigators must recognize the need to beall in, with a clear-eyed awareness of the rigor, focus,
and time commitment required to be prepared and
trained for this role. That path often includes a
K award early in the process. We have described
strategies for success for obtaining a K award, but
also for other aspects of development at this early
stage (Central Illustration). The transition between a
K award and an independent R01 has its own strate-
gies and challenges, which we have alluded to, but
not covered in detail. As emphasized, this is not a
recipe or manual to simply read and follow; one
needs to be connected with a mentor or mentors to
truly learn how to operationalize and execute these
strategies to ﬂourish.
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